Mr. Chris Monahan

• 
  www.spectrx.com/pressreldata.asp?PRID=299 - [Cached Version]
  Published on: 10/10/2006    Last Visited: 3/5/2007  

  Director Chris Monahan Retires
  
  Norcross, GA (October 10, 2006) -- SpectRx, Inc. (OTCBB: SPRX) today announced the retirement of Director Chris Monahan.The previously announced retirement is effective October 9, 2006.Mr. Monahan, 67, served as a Director of SpectRx, Inc. since September 2000.A search for his successor is underway.
  
  "Chris has been an excellent director for the company and a mentor to me personally," said Mark A. Samuels, SpectRx, Inc. chairman and chief executive officer.

• 
  www.sec.gov/Archives/edgar/data/924515/0000924515-04-00 - [Cached Version]
  Published on: 4/23/2004    Last Visited: 7/28/2004  

  Christopher F. Monahan
  ...
  ,Christopher F. Monahan has served as a member of our board of directors since October 2000.Mr. Monahan has been a private investor since 1998, following a 38-year career in the medical industry.Most recently, Mr. Monahan served as the divisional vice president and general manager in the Diagnostics Division of Abbott Laboratories, from 1992 to 1998.From 1988 to 1992 he served as president of Unipath, a division of the Unilever Co., and was responsible for its worldwide hematology business and marketing of the U.S. Clearview Rapid Assay line.From 1981 to 1988, Mr. Monahan was president and chief executive officer of Sequesta Turner Corp.Mr. Monahan earned a B.A. from the University of Notre Dame.

• 
  www.spectrx.com/newsreleasesbyyear.asp?PRYR=2000 - [Cached Version]
  Last Visited: 3/4/2008  

  Announces Appointment to Its Board of Directors Of Chris Monahan, Retired Abbott Laboratories Executive

• 
  Bizjournal - Hospitals on HealthBond - [Cached Version]
  Published on: 5/17/2005    Last Visited: 10/12/2006  

  SpectRx Inc. board member Chris Monahan, who had been a director since September 2000, has retired. Opinion: Add

• 
  CLP Magazine Department - [Cached Version]
  Published on: 11/1/2000    Last Visited: 3/15/2001  

  SpectRx , Inc. of Norcross , Ga. , appointed to its board of directors , Chris Monahan ( left ) , former divisional vice president and general manager with Abbott Laboratories' Diagnostics Division.SpectRx , in collaboration with Abbott and its MediSense Products unit , is developing a continuous glucose monitor for diabetics.Monahan joined Abbott's Diagnostics Division in 1992 as vice president and general manager of hematology , following the company's acquisition of Unilever's hematology business.Monahan had previously served as president of Unilever's Unipath Division and as president and CEO of Sequoia Turner Corp. , prior to its acquisition by Unilever.He has also had top-level management positions with Coherent Inc. , Baxter Travanol Laboratories , Inc. and Warner Lambert Co.Most recently he served as acting CEO for Informed Diagnostics , Inc. , and consults for medical companies.
  
  November 1 , 2000 , DATE : [ 11/01/2000 ]

• 
  HINN-- News Articles - [Cached Version]
  Published on: 12/21/1999    Last Visited: 9/17/2000  

  SpectRx, Inc. Announces Appointment to its Board of Directors Of Chris Monahan, Retired Abbott Laboratories ExecutiveThursday, September 14, 2000, DATE : [ 09/14/2000 ]
  
  ...
  SpectRx, Inc. today announced the appointment to its Board of Directors of Chris Monahan, a former Divisional Vice President and General Manager within Abbott Laboratories Diagnostics Division. ... [ Read ].
  
  Source : Yahoo
  
  y& ; industry=null& ; curpa12 13 14 15 16 17 18 19 20?category=industry& ; industry=null33 34 35 36 37 38 39 40?category=industry& ; industry=null53 54 55 56 57 58 59 60?category=industry& ; industry=null73 74 75 76 77 78 79 80

• 
  IndieLondon: The Rivals - Richmond Theatre - [Cached Version]
  Published on: 3/13/2005    Last Visited: 7/14/2006  

  The director, Christopher Monahan, appears to have decided the best way to combat the plot's inherent artificiality is to take everything at breakneck speed, salted with an element of over-emphasis with the result the cast gabbled their lines at such a pace as to be virtually inaudible and waved their arms about as if to semaphore the meanings of their dramatic emotions to the audience.
  
  The character which suffered most from this was Mrs Malaprop whose raison d'etre is the fact that she mixes up her words and it is therefore imperative that her dialogue should be sharp and crisp.
  ...
  A view obviously not endorsed by Mr Monahan as this unhappy production evidences.

• 
  October 10, 2006 Breaking News - [Cached Version]
  Published on: 10/10/2006    Last Visited: 10/21/2006  

  SpectRx, Inc. (SPRX) Director Chris Monahan Retires

• 
  October 10, 2006 Breaking News - [Cached Version]
  Published on: 10/10/2006    Last Visited: 11/13/2006  

  SpectRx, Inc. (SPRX) Director Chris Monahan Retires

• 
  SEC EDGAR Submission 0000924515-05-000007 - [Cached Version]
  Published on: 5/10/2005    Last Visited: 5/11/2005  

  Christopher F. Monahan
  ...
  ,Christopher F. Monahan has served as a member of our board of directors since October 2000.Mr. Monahan has been a private investor since 1998, following a 38-year career in the medical industry.Most recently, Mr. Monahan served as the divisional vice president and general manager in the Diagnostics Division of Abbott Laboratories, from 1992 to 1998.From 1988 to 1992 he served as president of Unipath, a division of the Unilever Co., and was responsible for its worldwide hematology business and marketing of the U.S. Clearview Rapid Assay line.From 1981 to 1988, Mr. Monahan was president and chief executive officer of Sequesta Turner Corp.Mr. Monahan earned a B.A. from the University of Notre Dame.

Page:  1 2